Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Incyte Corporation; Jazz Pharmaceuticals; Kadmon Corporation, LLC; Mallinckrodt Pharmaceuticals; and Takeda Oncology.

Community Practice Connections™: The Evolving Treatment Landscape for Patients With GvHD: More Options, More Decisions, Better Outcomes!

Release Date: January 31, 2020
Expiration Date: January 31, 2021
Media: Internet - based

Activity Overview

Community Practice Connections™: The Evolving Treatment Landscape for Patients With GvHD: More Options, More Decisions, Better Outcomes! consists of a series of short video interviews of leading experts in allogeneic hematopoietic transplantation, and brief summaries of recent clinical data with a focus on the newest approvals for treating graft-versus-host disease (GvHD). The video interviews address questions commonly faced in the community oncology practice setting.

Benefits of Participating

  • Hear experts talk about emerging therapies for GvHD
  • Gain insights regarding GvHD prophylaxis
  • Learn about algorithms for stratifying risk in GvHD
  • Obtain insight into survivorship care

Acknowledgement of Commercial Support

This activity is supported by educational grants from Incyte Corporation; Jazz Pharmaceuticals; Kadmon Corporation, LLC; Mallinckrodt Pharmaceuticals; and Takeda Oncology.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Videos” will be available for your reference.
  • In order to receive a CME Certificate, you must complete the activity.
  • Complete the Posttest and the Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Target Audience

This activity is intended for hematologists, medical oncologists, and other healthcare professionals who treat patients with GvHD. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the treatment of patients with GvHD are also invited to attend.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify recent advances regarding understanding of the biology of GvHD, with the potential to improve the ability to predict GvHD occurrence and plan treatment strategies
  • Evaluate recent clinical trial data regarding emerging treatment strategies for acute and chronic GvHD
  • Outline current and emerging prophylactic strategies for the prevention of GvHD onset
  • Integrate emerging options for prophylaxis and management into plans of care for patients at risk of developing GvHD

Faculty, Staff, and Planners’ Disclosures

Faculty

Corey S. Cutler
Corey S. Cutler, MD, MPH, FRCP(C)
Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, MA

Disclosures: Consultant: Genentech, Pharmacyclics LLC, Incyte Corporation, Fate Therapeutics, Bristol-Myers Squibb, Kadmon Corporation.

James L. M. Ferrara
James L. M. Ferrara, MD, DSc
Ward-Coleman Chair in Cancer Medicine
Professor of Medicine and Pediatrics
Director, Hematologic Malignancies Translational Research Center
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Patent for Biomarkers of Acute GvHD: IC Licensed to ViraCor Eurofins Laboratories.

Shernan Holtan
Shernan Holtan, MD
Associate Professor of Medicine
Division of Hematology, Oncology, and Transplantation
University of Minnesota
Minneapolis, MN

Disclosures: Consultant: Incyte Corporation, Bristol-Myers Squibb, CSL Behring, Janssen Pharmaceuticals, Inc; Speakers Bureau: Incyte Corporation, Roche.

Madan Jagasia
Madan Jagasia, MD,MS, MMHC
Professor of Medicine, Division of Hematology-Oncology
Chief Medical Officer, Vanderbilt-Ingram Cancer Center
Co-Leader, Translational Research and Interventional Oncology Research Program
Vanderbilt University Medical Center
Nashville, TN

Disclosures: Grant Research Support: Mallinckrodt Pharmaceuticals, Janssen Pharmaceuticals, Inc.

Iskra Pusic
Iskra Pusic, MD
Assistant Professor
Department of Medicine, Oncology Division
Bone Marrow Transplantation & Leukemia
Washington University School of Medicine
St. Louis, MO

Disclosures: Consultant: Advisory Board for Kamon Pharmaceuticals.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest (COI).

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or any of the companies that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
Filter By